These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32573944)

  • 1. A combined CaMKII inhibition and mineralocorticoid receptor antagonism via eplerenone inhibits functional deterioration in chronic pressure overloaded mice.
    Driessen HE; Fontes MS; van Stuijvenberg L; Brans MA; Goumans MJ; Vos MA; van Veen TA
    J Cell Mol Med; 2020 Aug; 24(15):8417-8429. PubMed ID: 32573944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.
    Federico M; Portiansky EL; Sommese L; Alvarado FJ; Blanco PG; Zanuzzi CN; Dedman J; Kaetzel M; Wehrens XHT; Mattiazzi A; Palomeque J
    J Physiol; 2017 Jun; 595(12):4089-4108. PubMed ID: 28105734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity.
    Lother A; Bergemann S; Kowalski J; Huck M; Gilsbach R; Bode C; Hein L
    Cardiovasc Res; 2018 Feb; 114(2):282-290. PubMed ID: 28430882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model.
    Stein M; Boulaksil M; Jansen JA; Herold E; Noorman M; Joles JA; van Veen TA; Houtman MJ; Engelen MA; Hauer RN; de Bakker JM; van Rijen HV
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H310-21. PubMed ID: 20435847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.
    Diaz-Otero JM; Yen TC; Fisher C; Bota D; Jackson WF; Dorrance AM
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1304-H1315. PubMed ID: 30118343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca
    Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
    J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition ameliorates arrhythmias elicited by junctin ablation under stress conditions.
    Tzimas C; Terrovitis J; Lehnart SE; Kranias EG; Sanoudou D
    Heart Rhythm; 2015 Jul; 12(7):1599-610. PubMed ID: 25814413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor and cardiac arrhythmia.
    Gravez B; Tarjus A; Jaisser F
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):910-5. PubMed ID: 23888997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absent.
    Takanari H; Bourgonje VJ; Fontes MS; Raaijmakers AJ; Driessen H; Jansen JA; van der Nagel R; Kok B; van Stuijvenberg L; Boulaksil M; Takemoto Y; Yamazaki M; Tsuji Y; Honjo H; Kamiya K; Kodama I; Anderson ME; van der Heyden MA; van Rijen HV; van Veen TA; Vos MA
    Cardiovasc Res; 2016 Sep; 111(4):410-21. PubMed ID: 27357638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity.
    Grune J; Beyhoff N; Smeir E; Chudek R; Blumrich A; Ban Z; Brix S; Betz IR; Schupp M; Foryst-Ludwig A; Klopfleisch R; Stawowy P; Houtman R; Kolkhof P; Kintscher U
    Hypertension; 2018 Apr; 71(4):599-608. PubMed ID: 29437893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eplerenone Improves Pulmonary Vascular Remodeling and Hypertension by Inhibition of the Mineralocorticoid Receptor in Endothelial Cells.
    Kowalski J; Deng L; Suennen C; Koca D; Meral D; Bode C; Hein L; Lother A
    Hypertension; 2021 Aug; 78(2):456-465. PubMed ID: 33966455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized CaMKII (Ca
    Wang Q; Quick AP; Cao S; Reynolds J; Chiang DY; Beavers D; Li N; Wang G; Rodney GG; Anderson ME; Wehrens XHT
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005682. PubMed ID: 29654126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPA1 ion channel stimulation enhances cardiomyocyte contractile function via a CaMKII-dependent pathway.
    Andrei SR; Ghosh M; Sinharoy P; Dey S; Bratz IN; Damron DS
    Channels (Austin); 2017 Nov; 11(6):587-603. PubMed ID: 28792844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaMKII inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-B syndrome.
    DeGrande S; Nixon D; Koval O; Curran JW; Wright P; Wang Q; Kashef F; Chiang D; Li N; Wehrens XH; Anderson ME; Hund TJ; Mohler PJ
    Heart Rhythm; 2012 Dec; 9(12):2034-41. PubMed ID: 23059182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.